Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

4 structures for Q5TDH0

Entry ID Method Resolution Chain Position Source
2N7D NMR - A 1-76 PDB
4RGH X-ray 190 A A/B 212-360 PDB
5K57 NMR - A 116-212 PDB
AF-Q5TDH0-F1 Predicted AlphaFoldDB

213 variants for Q5TDH0

Variant ID(s) Position Change Description Diseaes Association Provenance
TCGA novel 11 D>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA615850
rs774392792
12 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs1384906915
CA338570628
13 S>C No ClinGen
TOPMed
rs1179005250
CA338570682
18 S>F No ClinGen
gnomAD
rs1453273114
CA338570687
19 L>F No ClinGen
TOPMed
gnomAD
rs993388122
CA18272524
CA338570742
24 D>E No ClinGen
TOPMed
gnomAD
rs772904667
CA615853
24 D>N No ClinGen
ExAC
gnomAD
CA338570754
rs373032236
25 F>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA18272529
rs1030186328
25 F>L No ClinGen
TOPMed
CA338570801
rs1301687624
29 N>S No ClinGen
gnomAD
CA338570822
rs1236374987
31 R>C No ClinGen
gnomAD
CA615859
rs764486414
36 L>F No ClinGen
ExAC
gnomAD
CA615858
rs764486414
36 L>V No ClinGen
ExAC
gnomAD
rs1426251270
CA338571002
42 A>T No ClinGen
gnomAD
CA615863
rs756264292
44 E>* No ClinGen
ExAC
gnomAD
CA338571071
rs1382395013
46 Q>E No ClinGen
gnomAD
CA338573376
rs774889431
47 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA615880
rs769311230
47 I>V No ClinGen
ExAC
gnomAD
CA615882
rs762325900
48 V>I No ClinGen
ExAC
gnomAD
CA338573414
rs190145902
49 Y>C No ClinGen
1000Genomes
ExAC
gnomAD
CA615883
rs190145902
49 Y>F No ClinGen
1000Genomes
ExAC
gnomAD
rs1384277523
COSM1319832
CA338573595
57 N>S ovary Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1307400915
CA338573732
63 S>F No ClinGen
gnomAD
CA615887
rs77782333
66 L>F No ClinGen
ExAC
gnomAD
CA615888
rs755177299
67 K>* No ClinGen
ExAC
gnomAD
rs755177299
CA615889
67 K>E No ClinGen
ExAC
gnomAD
CA338573782
rs752722490
67 K>I No ClinGen
ExAC
TOPMed
gnomAD
CA615890
rs752722490
67 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1570967814
CA338573801
68 D>E No ClinGen
Ensembl
CA615892
rs777917292
68 D>N No ClinGen
ExAC
rs150610844
CA338573828
70 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs921001720
CA18277636
70 D>G No ClinGen
Ensembl
rs1570967828
CA338573848
71 V>G No ClinGen
Ensembl
CA18277638
rs913479339
72 V>L No ClinGen
Ensembl
CA338573874
rs1193627726
73 I>F No ClinGen
TOPMed
rs1193627726
CA338573863
73 I>V No ClinGen
TOPMed
CA18277639
rs374425147
75 R>Q No ClinGen
ESP
TOPMed
gnomAD
TCGA novel 77 K>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs144340720
CA615895
79 N>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1172758195
CA338573997
81 D>H No ClinGen
gnomAD
CA338574039
rs202121145
83 R>P No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs202121145
CA615896
83 R>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA615897
rs769348446
85 P>L No ClinGen
ExAC
gnomAD
CA338574090
rs1360520897
87 Q>H No ClinGen
gnomAD
rs757208866
CA615898
88 F>L No ClinGen
ExAC
TOPMed
gnomAD
CA18277641
rs942711022
90 N>D No ClinGen
Ensembl
CA338574455
rs1341668545
92 P>L No ClinGen
gnomAD
CA338574444
rs1163691797
92 P>S No ClinGen
TOPMed
CA338574447
rs1163691797
92 P>T No ClinGen
TOPMed
rs779619064
CA615917
93 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs535427500
CA18282287
96 F>S No ClinGen
Ensembl
CA615919
rs768110369
99 I>V No ClinGen
ExAC
gnomAD
rs773869764
CA338574948
100 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs773869764
CA615920
100 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs371977898
CA615921
106 S>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA615922
rs764466841
107 P>L No ClinGen
ExAC
gnomAD
CA338575049
rs1218866996
107 P>S No ClinGen
gnomAD
rs1218866996
CA338575045
107 P>T No ClinGen
gnomAD
rs140092977
CA615925
108 R>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA615924
rs140092977
COSM2084672
108 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA615923
rs564313462
108 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA615926
rs757729580
COSM1194696
110 R>C lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs148633078
CA615927
110 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA338575115
rs1433275542
111 Q>H No ClinGen
gnomAD
CA338575136
rs1570970400
113 P>Q No ClinGen
Ensembl
rs1157565702
CA338575162
115 T>A No ClinGen
gnomAD
CA615928
rs764221560
115 T>R No ClinGen
ExAC
gnomAD
CA615929
rs746374554
117 Q>L No ClinGen
ExAC
TOPMed
gnomAD
CA338575219
rs757198316
118 S>C No ClinGen
ExAC
gnomAD
rs757198316
CA615930
118 S>F No ClinGen
ExAC
gnomAD
rs532223617
CA615931
119 H>R No ClinGen
1000Genomes
ExAC
gnomAD
rs750222182
CA338575245
120 S>* No ClinGen
ExAC
gnomAD
rs750222182
CA615932
120 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1199146683
CA338575248
121 S>P No ClinGen
TOPMed
rs1263185583
CA338575265
122 P>L No ClinGen
gnomAD
rs1437621829
CA338575275
123 G>V No ClinGen
TOPMed
gnomAD
CA338575327
rs1446115383
128 S>P No ClinGen
TOPMed
rs748839324
CA615935
129 P>H No ClinGen
ExAC
TOPMed
gnomAD
CA338575359
rs748839324
129 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA615934
rs779927649
129 P>S No ClinGen
ExAC
gnomAD
COSM1295317
CA338575368
rs1416854324
130 Q>* Variant assessed as Somatic; impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA18282351
rs1007597309
130 Q>R No ClinGen
Ensembl
CA18282354
rs943607068
132 L>M No ClinGen
TOPMed
gnomAD
rs1206771546
CA338575409
132 L>W No ClinGen
gnomAD
CA338575440
rs1291945173
134 N>S No ClinGen
gnomAD
rs1247301536
CA338575473
136 A>G No ClinGen
gnomAD
rs1452177258
CA338575464
136 A>T No ClinGen
gnomAD
rs771412314
CA615939
139 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1000212771
CA18282377
141 M>T No ClinGen
TOPMed
CA615940
rs777052167
141 M>V No ClinGen
ExAC
gnomAD
rs1570970480
CA338575597
143 L>V No ClinGen
Ensembl
rs865796587
CA338575614
144 A>G No ClinGen
gnomAD
rs1225575960
CA338575612
144 A>S No ClinGen
TOPMed
rs865796587
CA18282385
144 A>V No ClinGen
gnomAD
rs1422219205
CA338575628
145 N>S No ClinGen
gnomAD
rs746213909
CA615941
146 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs746213909
CA338575649
146 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA338575644
rs1307767204
146 P>S No ClinGen
TOPMed
CA18282387
rs972192119
149 L>M No ClinGen
TOPMed
rs1375179886
CA338575734
150 S>F No ClinGen
gnomAD
COSM898045
CA18282409
rs1053156819
155 R>C Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs763211597
CA615945
155 R>H No ClinGen
ExAC
gnomAD
CA615946
rs368189349
156 N>S No ClinGen
ExAC
gnomAD
CA615949
rs767454817
162 A>S No ClinGen
ExAC
gnomAD
CA338575906
rs1198808826
164 L>F No ClinGen
gnomAD
CA615951
rs750285872
COSM310502
165 S>C lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs750285872
CA615950
165 S>G No ClinGen
ExAC
TOPMed
gnomAD
rs754242472
CA18282428
165 S>T No ClinGen
Ensembl
CA338576082
rs1570972882
173 R>T No ClinGen
Ensembl
rs551131914
CA18284700
174 V>L No ClinGen
1000Genomes
CA338576095
rs1570972889
175 L>R No ClinGen
Ensembl
rs1318333908
CA338576127
180 Q>E No ClinGen
TOPMed
CA18284702
rs922851617
181 D>E No ClinGen
TOPMed
CA615976
rs777089239
182 R>* No ClinGen
ExAC
gnomAD
rs777089239
CA615977
182 R>G No ClinGen
ExAC
gnomAD
rs756578455
CA615978
182 R>Q No ClinGen
ExAC
TOPMed
CA338576143
rs1570972905
183 A>T No ClinGen
Ensembl
rs769099374
CA615981
184 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA615980
rs749651325
184 R>W No ClinGen
ExAC
gnomAD
rs1282349622
CA338576167
187 Q>K No ClinGen
TOPMed
gnomAD
rs748318737
CA615983
190 I>V No ClinGen
ExAC
gnomAD
rs772339357
CA615984
191 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA615985
rs773160744
191 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs1349592093
CA338576225
196 D>N No ClinGen
gnomAD
CA338576273
rs1557615291
202 A>V No ClinGen
Ensembl
TCGA novel 204 A>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA338576290
rs1557615300
205 K>E No ClinGen
Ensembl
rs199886079
CA18284773
205 K>R No ClinGen
1000Genomes
CA338576324
rs1277952417
209 D>V No ClinGen
TOPMed
rs1489539935
CA338576330
210 I>K No ClinGen
gnomAD
rs1441214266
CA338576328
210 I>V No ClinGen
TOPMed
rs770750343
CA615987
211 R>W No ClinGen
ExAC
gnomAD
rs1314068129
CA338576889
220 T>A No ClinGen
gnomAD
rs758837543
CA616021
226 A>V No ClinGen
ExAC
gnomAD
TCGA novel 231 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA338577059
rs1209727040
234 V>M No ClinGen
gnomAD
rs1235762935
CA338577102
238 I>V No ClinGen
gnomAD
CA616025
rs781184565
244 G>A No ClinGen
ExAC
gnomAD
rs781184565
CA338577178
244 G>E No ClinGen
ExAC
gnomAD
CA616026
rs746015730
245 H>Y No ClinGen
ExAC
TOPMed
gnomAD
CA338578395
rs1477574744
257 M>T No ClinGen
gnomAD
CA338578506
rs1170661072
262 Q>* No ClinGen
gnomAD
CA18293187
rs374058645
267 R>G No ClinGen
ESP
rs763390859
CA616041
276 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs764463034
CA616042
276 R>H No ClinGen
ExAC
gnomAD
rs764463034
CA338578838
276 R>P No ClinGen
ExAC
gnomAD
rs1300606561
COSM898056
CA338578846
277 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA18293213
rs6669070
278 W>R No ClinGen
Ensembl
rs1165850708
CA338578886
279 A>V No ClinGen
TOPMed
gnomAD
CA338578954
rs1386776120
285 V>L No ClinGen
gnomAD
rs938357515
CA18293234
287 T>I No ClinGen
gnomAD
COSM218341
rs1369959431
CA338579005
289 K>N pancreas [Cosmic] No ClinGen
cosmic curated
gnomAD
TCGA novel 289 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 293 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs750482430
CA616046
296 L>I No ClinGen
ExAC
gnomAD
rs754927091
CA616068
299 V>L No ClinGen
ExAC
gnomAD
TCGA novel 300 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA338579974
rs1367413243
300 Q>E No ClinGen
gnomAD
CA338579986
rs1472728171
300 Q>H No ClinGen
gnomAD
TCGA novel 304 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760728983
CA18298260
309 S>F No ClinGen
Ensembl
rs747919609
CA616070
311 S>C No ClinGen
ExAC
TOPMed
gnomAD
CA616071
rs771951356
312 I>L No ClinGen
ExAC
gnomAD
rs777733245
CA616072
314 E>Q No ClinGen
ExAC
gnomAD
rs1398346703
CA338580237
314 E>V No ClinGen
gnomAD
rs1056577268
CA18298272
320 M>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 322 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770495140
CA616074
326 M>I No ClinGen
ExAC
CA338580509
rs1210367910
326 M>V No ClinGen
TOPMed
CA616075
rs776201705
329 R>Q No ClinGen
ExAC
gnomAD
rs746867512
CA616092
333 S>A No ClinGen
ExAC
gnomAD
rs535658184
CA616093
333 S>C No ClinGen
1000Genomes
ExAC
gnomAD
rs920969914
CA18300084
335 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA338581404
rs1201647951
337 K>T No ClinGen
gnomAD
CA616095
rs147540527
338 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA338581433
rs1365098616
340 V>I No ClinGen
TOPMed
CA18300102
rs1023503619
341 L>F No ClinGen
TOPMed
gnomAD
CA338581454
rs1193604934
342 V>M No ClinGen
gnomAD
rs772629723
CA616099
343 I>F No ClinGen
ExAC
gnomAD
CA18300150
rs369260788
343 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs773548713
CA616100
343 I>T No ClinGen
ExAC
gnomAD
rs890895394
CA18300151
344 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA616103
rs776675686
347 G>D No ClinGen
ExAC
gnomAD
CA338581494
rs1399191853
349 Q>K No ClinGen
TOPMed
CA616106
rs147295688
356 G>A No ClinGen
ESP
ExAC
gnomAD
rs758406834
CA616107
360 E>A No ClinGen
ExAC
gnomAD
CA338581616
rs139539436
363 R>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA616109
rs751379257
363 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs139539436
CA616108
363 R>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1284500174
CA338581630
364 L>F No ClinGen
gnomAD
rs1570987677
CA338581661
368 A>T No ClinGen
Ensembl
rs1431618713
CA338581674
369 G>E No ClinGen
gnomAD
rs1195759721
CA338581678
370 R>G No ClinGen
gnomAD
rs781075305
CA616111
370 R>K No ClinGen
ExAC
gnomAD
TCGA novel 371 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1273098095
CA338581701
372 D>N No ClinGen
TOPMed
rs1439155450
CA338581713
373 V>I No ClinGen
gnomAD
CA338581725
rs755808289
374 R>L No ClinGen
ExAC
gnomAD
CA616113
rs755808289
374 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA616112
rs373473419
374 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs150526409
CA616114
375 P>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1388334338
CA338581737
376 E>Q No ClinGen
gnomAD
rs543837249
CA616117
382 E>V No ClinGen
1000Genomes
ExAC
gnomAD
CA338581822
rs1557622271
383 L>V No ClinGen
Ensembl
rs1027637294
CA18300243
387 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA338581871
rs1252197053
387 L>H No ClinGen
TOPMed
rs1310884009
CA338581896
388 Q>H No ClinGen
gnomAD
CA338581966
rs1197577226
391 A>V No ClinGen
TOPMed
CA616119
rs771151057
394 A>P No ClinGen
ExAC
TOPMed
gnomAD
rs781405060
CA616140
396 R>C No ClinGen
ExAC
gnomAD
rs200176580
CA616141
396 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA18304236
rs1051664341
398 K>* No ClinGen
Ensembl
rs770119825
CA616142
400 P>R No ClinGen
ExAC
TOPMed
gnomAD

No associated diseases with Q5TDH0

3 regional properties for Q5TDH0

Type Name Position InterPro Accession
domain Ubiquitin-like domain 1 - 81 IPR000626
domain Aspartic peptidase, DDI1-type 212 - 343 IPR019103
domain DNA damage inducible protein 1 ubiquitin-like domain 1 - 76 IPR033882

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm, cytosol
  • Chromosome
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
chromosome A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.

3 GO annotations of molecular function

Name Definition
aspartic-type endopeptidase activity Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile.
identical protein binding Binding to an identical protein or proteins.
ubiquitin binding Binding to ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation.

5 GO annotations of biological process

Name Definition
cellular response to hydroxyurea Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroxyurea stimulus.
proteasomal protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome.
protein processing Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein.
regulation of DNA stability Any process that modulates the stability of DNA.
regulation of protein stability Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
A2ADY9 Ddi2 Protein DDI1 homolog 2 Mus musculus (Mouse) PR
Q497D6 ddi2 Protein DDI1 homolog 2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MLLTVYCVRR DLSEVTFSLQ VDADFELHNF RALCELESGI PAAESQIVYA ERPLTDNHRS
70 80 90 100 110 120
LASYGLKDGD VVILRQKENA DPRPPVQFPN LPRIDFSSIA VPGTSSPRQR QPPGTQQSHS
130 140 150 160 170 180
SPGEITSSPQ GLDNPALLRD MLLANPHELS LLKERNPPLA EALLSGDLEK FSRVLVEQQQ
190 200 210 220 230 240
DRARREQERI RLFSADPFDL EAQAKIEEDI RQQNIEENMT IAMEEAPESF GQVVMLYINC
250 260 270 280 290 300
KVNGHPVKAF VDSGAQMTIM SQACAERCNI MRLVDRRWAG IAKGVGTQKI IGRVHLAQVQ
310 320 330 340 350 360
IEGDFLPCSF SILEEQPMDM LLGLDMLKRH QCSIDLKKNV LVIGTTGSQT TFLPEGELPE
370 380 390
CARLAYGAGR EDVRPEEIAD QELAEALQKS AEDAERQKP